MetLife Investment Advisors »

BioMarin Pharmaceutical shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.7M 105k 54.16
2025-06-30 $6.0M 109k 54.97
2025-03-31 $7.5M 106k 70.69
2024-12-31 $7.1M 107k 65.73
2024-09-30 $6.9M 98k 70.29
2024-06-30 $8.2M 100k 82.33
2023-12-31 $439k 4.6k 96.42
2023-09-30 $410k 4.6k 88.48
2023-06-30 $401k 4.6k 86.68
2023-03-31 $372k 3.8k 97.24
2022-12-31 $395k 3.8k 103.49
2022-09-30 $322k 3.8k 84.77
2022-06-30 $322k 3.9k 82.82
2022-03-31 $281k 3.6k 77.05
2021-09-30 $280k 3.6k 77.29
2021-03-31 $26k 340 75.51
2019-03-31 $22k 242 88.83
2018-12-31 $21k 241 85.15
2018-09-30 $24k 243 96.97